Anticoagulant Citrate Phosphate Dextrose (CPD) Blood-Pack Units in PL 146 Plastic
Active substance: TRISODIUM CITRATE DIHYDRATE, DEXTROSE MONOHYDRATE, ANHYDROUS CITRIC ACID, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE
SOLUTION · TRISODIUM CITRATE DIHYDRATE 921 mg/35mL, DEXTROSE MONOHYDRATE 893 mg/35mL, ANHYDROUS CITRIC ACID 105 mg/35mL, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE 78 mg/35mL
United StatesActive
Marketing holder: Fenwal, Inc.
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- TRISODIUM CITRATE DIHYDRATE · 921 mg/35mL
- DEXTROSE MONOHYDRATE · 893 mg/35mL
- ANHYDROUS CITRIC ACID · 105 mg/35mL
- SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE · 78 mg/35mL
Registration
- Registration number
- 0942-9201
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRAVENOUS
Sources
- product · openFDA NDC · 0942-9201 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 0942-9201 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 0942-9201 · Verified 2026-10-09 · open in source
- ingredients.1 · openFDA NDC · 0942-9201 · Verified 2026-10-09 · open in source
- ingredients.2 · openFDA NDC · 0942-9201 · Verified 2026-10-09 · open in source
- ingredients.3 · openFDA NDC · 0942-9201 · Verified 2026-10-09 · open in source